The Evolution of Muscarinic Therapies : A New Era in Treating Schizophrenia and Other Neuropsychiatric Disorders
Time: 9:00 am
day: Day One
Details:
- The discovery of anti-psychotic drugs
- The history and mode of action of xanomeline in early Alzheimer’s studies
- Exploring the potential efficacy of mAChR agonists for treating all three core symptom domains of schizophrenia, and in other indications, such as: dementiaassociated psychosis, Alzheimer’s disease , Parkinson’s psychosis , bipolar disorder and more
